Duloxetine Delayed-Release (duloxetine hydrochloride) NDC 71610-218

Product information

Brand name (proprietary)

Duloxetine Delayed-ReleaseSuffix: Delayed-Release

Generic name (nonproprietary)

duloxetine hydrochloride

Active ingredients

Duloxetine hydrochloride — 30 mg/1

Dosage form

Capsule, Delayed release pellets

Route

Oral

Labeler

Aphena Pharma Solutions - Tennessee, LLC

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 203088

Marketing start

Jun 11, 2014

Listing expires

Dec 31, 2026

Other FDA classes

Norepinephrine Uptake Inhibitors (Mechanism)Serotonin Uptake Inhibitors (Mechanism)

Identifiers

Product ID 71610-218_492c2d4f-3ba2-4858-bfbb-8ade6b3b7e30SPL ID 492c2d4f-3ba2-4858-bfbb-8ade6b3b7e30SPL set ID db686a0a-9b2a-4017-8bd1-b981da47c2f3RxCUI 596930UNII 9044SC542W

Pharmacologic class

Serotonin and Norepinephrine Reuptake Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471610021830 followed by a unit qualifier and the quantity Copy

Package 71610-0218-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Other NDCs under ANDA 203088

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

Showing 20 of 36.